RNO
Rhinomed
- Short interest
- <0.01%
- as of 8 Jan 2015
- Reported shorts
- 4.4K
- Shares on issue
- 539.439M
Rhinomed (RNO) financials
Results, ratios and statements
Fundamentals
Our data providers hold no financial statements for RNO (last checked 15 Oct 2026). The company's own filings are listed below.
Financial reports
The company's own filings, newest first
- Monthly Activities/Appendix 4C Cash Flow ReportQuarterly Report31 Jan 2024via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report27 Oct 2023via asx_announcements
- Notice of Annual General Meeting/Proxy FormAgm Address18 Oct 2023via asx_announcements
- Annual Report to shareholders 2023Annual Report18 Oct 2023via asx_announcements
- Preliminary Final ReportAnnual Results31 Aug 2023via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report31 Jul 2023via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report28 Apr 2023via asx_announcements
- Half Yearly Report and AccountsHalf Year Results28 Feb 2023via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report30 Jan 2023via asx_announcements
- Chairman's Address to Shareholders 2022 AGMAgm Address18 Nov 2022via asx_announcements
Showing 10 of 65 reports